| DC Field | Value | Language |
|---|
| dc.contributor.author | Cojocari, Felicia | - |
| dc.date.accessioned | 2020-07-06T10:51:44Z | - |
| dc.date.available | 2020-07-06T10:51:44Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | COJOCARI, Felicia. The impact of statins on the metabolism of patients with cardiovascular disease. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 45-46. | en_US |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10995 | - |
| dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova | en_US |
| dc.description.abstract | Introduction. Statins are a class of lipid-lowering medications, also known as HMG-CoA
reductase inhibitors. They are considered one of the most popular prescribed agents worldwide
for treatment of hypercholesterolemia. Statins are effective drugs to reduce cardiovascular events and mortality secondary to dyslipidemia. Statin therapy is considered as the standard
dyslipidemia therapy. Except lipid-lowering effect, it is known that statins have cholesterolindependent
effects (pleiotropic effects). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | statins | en_US |
| dc.subject | pleiotropic effects | en_US |
| dc.subject | cardiovascular diseases | en_US |
| dc.title | The impact of statins on the metabolism of patients with cardiovascular disease | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2018
|
